Dr. Hamburg was nominated by President Barack Obama and confirmed by the U.S. Senate in May 2009, making her the second woman to serve as the FDA commissioner.
During her tenure, Dr. Hamburg oversaw a variety of public health initiatives and issues including disease control, drug development and approvals, emergency contraceptives, food inspection and safety, personalized medicine and tobacco control.
FDA Chief Scientist Stephen Ostroff, MD, will serve as commissioner until a new appointee is named.
More articles on the FDA:
FDA, CDC continue investigation into patient injected with simulated IV fluids
Study calls for more complete FDA data on drug side effects
Senator pushes for FDA action on scopes that led to infections at Virginia Mason
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
